The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
Open accessAbstract
Desmoplasia describes the deposition of extensive extracellular matrix and defines primary pancreatic ductal adenocarcinoma (PDA). The acellular component of this stroma has been implicated in PDA pathogenesis and is being targeted therapeutically in clinical trials. By analyzing the stromal content of PDA samples from numerous annotated PDA data sets and correlating stromal content with both anatomic site and clinical outcome, we found PDA metastases in the liver, the primary cause of mortality to have less stroma, have higher tumor cellularity than primary tumors. Experimentally manipulating stromal matrix with an anti-lysyl oxidase like-2 (anti-LOXL2) antibody in syngeneic orthotopic PDA mouse models significantly decreased matrix content, led to lower tissue stiffness, lower contrast retention on computed tomography, and accelerated tumor growth, resulting in diminished overall survival. These studies suggest an important protective role of stroma in PDA and urge caution in clinically deploying stromal depletion strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“depletion of stromal fibroblasts through hedgehog inhibition, epithelial sonic hedgehog deletion, stromal ablation, or inhibition of lysyl oxidase like-2 increases tumor access to the blood supply and facilitates metastasis, having deleterious consequences on natural history of the disease159–162”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [161]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Self-citationDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194
Self-citation
Cited by
Sorted by citations
Items 101–127 of 127
Khlebus, E., Vuttaradhi, V. K., Borgogno, S. F., Brodsky, A. L., Lawson, B. C., Mok, S. C., & Hillman, R. T. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0333 · Cited by 1
Navarro, Á. R., Martín, J. R., Gutiérrez, I. G. C., Amo‐Salas, M., Recuero‐Pradillo, M., Sánchez-Muñoz, C., Lázaro, C. M. M., López, E. C., Simón, R. S., Quimbayo-Arcila, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411795 · Cited by 1
Gastric cancer organoids and their convergence in engineering approaches
Lim, S., Kim, S. H., Hye‐Jin, J., Park, S., Koo, B., Lee, J., & Shin, W. (2026) · FEBS Letters · doi:10.1002/1873-3468.70272 · Cited by 2
Digital quantification of stroma percentage enhances prognostic stratification in pancreatic cancer
Bengtsson, A., Andersson, R. E., Andersson, B., & Ansari, D. (2026) · Surgery Open Science · doi:10.1016/j.sopen.2026.01.002 · Cited by 2
Kim, B., & Lee, J. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135682 · Cited by 1
A Presynaptic Protein Is a Net Gain for Pancreatic Tumor Progression
Sherman, M. H. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1645 · Cited by 1
Role of the Extracellular Matrix in Tumor Stroma: Barrier or Support?
Zeltz, C., Navab, R., Lü, N., Kusche‐Gullberg, M., Tsao, M., & Gullberg, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_5 · Cited by 1
Bouchart, C., Senar, O. A., Navez, J., Verset, L., Boisson, A., Hein, M., Stosic, K., Quertinmont, E., Tafciu, V., Zhao, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.30.591890 · Cited by 1
水害時における病院の危機管理--〔平成11年〕10・28岩手県豪雨軽米町水害を経験して (第39回 全国自治体病院学会(於:札幌)管理分科会の記録)
佐藤, 元., 小笠原, 雄., & 横島, 孝. (2001) · 事務管理の研究
Wei, D., Cheng, X., Du, C., Wang, Y., Sun, J., Li, C., Wu, J., Tian, X., Zhao, Y., Yang, Y., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4071781
Kuznetsova, A. V., Попова, О. П., Анатольевич, А. Д., Ivanov, Y. V., Панченков, Д. Н., & Aa, I. (2022) · Russian Journal of Archive of Pathology · doi:10.17116/patol20228405165
Mimicking Multicellular Features of the Tumor Microenvironment
Curvello, R., & Loessner, D. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166013-00141
Effects of cancer‐associated fibroblasts deletion using HSVtk suicide system in OSCC
Ye, C., Zhang, X., Wang, Y., Jing, Y., Song, Y., Celentano, A., & Ni, Y. (2023) · Oral Diseases · doi:10.1111/odi.14612
The Role of Lysine Tyrosylquinone Containing Oxidases in Progression of Solid Tumors
Korneenko, T. V., Pestov, N. B., & Barlev, N. A. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl36248
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916892
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916904
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916898
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916895
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916907
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916889
Resovi, A., Persichitti, P., Brunelli, L., Minoli, L., Borsotti, P., Garattini, G., Tironi, M., Dugnani, E., Redegalli, M., Simone, G. D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916901
Role of the stromal microenvironment in PDAC and resistance to therapies
Ode, A. (2024) · theses.fr (ABES) · doi:10.70675/0452e0e9z98e8z47d9za007zd4b472926aab
Yu, Y.-N., Jin, S.-Q., Lu, Y.-T., & Han, L.-Z. (2026) · World Journal of Clinical Oncology · doi:10.5306/wjco.v17.i4.117197
Doeve, B. H., Nissen, N. I., Weeda, V., Dings, M. P. G., Meijer, S. L., van Laarhoven, H. W. M., Bijlsma, M. F., & Willumsen, N. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261459109
Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironment
Torres-Sanchez, A., Dorta-Estremera, S. M., Carlo, V. P., & Dharmawardhane, S. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101335
Bugata, L. S. P., Dhar, D., Kant, R., Kumar, R., Kabir, M. I., Agarwal, C., Agarwal, R., & Raina, K. (2026) · Molecular Carcinogenesis · doi:10.1002/mc.70164
Wang, X., Xie, Z., Li, H., Tang, Q., Zhou, J., Huang, J., 方世武, Li, D., Li, L., Zeng, M., et al. (2026) · MedComm · doi:10.1002/mco2.71039
Metadata
- Authors
- Jiang, H., Torphy, R. J., Steiger, K., Hongo, H., Ritchie, A. J., Kriegsmann, M., Horst, D., Umetsu, S. E., Joseph, N. M., McGregor, K., Pishvaian, M. J., Blais, E. M., Lu, B., Li, M., Hollingsworth, M., Stashko, C., Volmar, K., Yeh, J. J., Weaver, V. M., Wang, Z. J., Tempero, M. A., Weichert, W., & Collisson, E. A.
- Affiliations
- University of California, San Francisco (US)
- University of Colorado Anschutz (US)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- University Hospital Heidelberg (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Foundation Medicine (United States) (US)
- Johns Hopkins University (US)
- Bristol-Myers Squibb (United States) (US)
- University of Nebraska Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Collisson, Eric A.
- ORCID
- Jiang, Honglin
- Torphy, Robert J.
- Steiger, Katja
- Hongo, Henry
- Kriegsmann, Mark
- Horst, David
- Umetsu, Sarah E.
- Joseph, Nancy M.
- McGregor, Kimberly
- Pishvaian, Michael J.
- Blais, Edik M.
- Lu, Brian
- Li, Mingyu
- Hollingsworth, Michael
- Stashko, Connor
- Yeh, Jen Jen
- Weaver, Valerie M.
- Wang, Zhen J.
- Tempero, Margaret A.
- Weichert, Wilko
- Collisson, Eric A.
- Venue
- Journal of Clinical Investigation
- Published
- 2020-08-04
- Volume
- 130
- Issue
- 9
- Pages
- 4704-4709
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7456216
- OpenAlex
- W3047538947
- Cited by
- 127
- References
- 30
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 14 · 2023: 25 · 2022: 31 · 2021: 24 · 2020: 3
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- UNC Libraries
- Funders
- National Cancer Institute (R01CA178015, R01CA227807, R01CA222862)
- National Institutes of Health (CA193650, CA199064, NCATS Colorado CTSA TL1 TR002533)
- Deutsche Forschungsgemeinschaft (329628492)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- pancreatic ductal adenocarcinoma, tumor stroma, desmoplasia, extracellular matrix, LOXL2, liver metastasis, tumor cellularity, tissue stiffness, tumor progression, overall survival, syngeneic mouse model
- MeSH terms
- Aged, Animals, Extracellular Matrix, Female, Humans, Male, Mice, Transgenic, Middle Aged, Pancreatic Neoplasms, Stromal Cells, Carcinoma, Pancreatic Ductal, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
